Health & Environmental Research Online (HERO)


Print Feedback Export to File
1274691 
Journal Article 
CJC-1131 - Agent for type 2 diabetes glucagon-like peptide-1 (GLP-1) analogue 
Davies, SJ; Martin, L; Castaner, RM 
2005 
0 
Drugs of the Future
ISSN: 0377-8282 
30 
6 
553-557 
L-histidyl-D-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-beryl-L-alpha-aspartyl-L-valyl-L-beryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl; L-tryptophyl-L-leucyl-L-valyl-L-lysylglycyl-L-arginyl-N-6-[2-[2-[2-[3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propionamido]ethoxy]ethoxy]acetyl]-L-lysinamide